GLC determination of propranolol, other beta-blocking drugs, and metabolites in biological fluids and tissues.
D000319:Adrenergic beta-Antagonists / Q000032:analysis*; D000526:Alprenolol / Q000032:analysis; D000818:Animals; D001826:Body Fluids / Q000032:analysis*; D002849:Chromatography, Gas / Q000379:methods; D004983:Ethanolamines / Q000032:analysis; D005463:Fluoroacetates / Q000652:urine; D006801:Humans; D007545:Isoproterenol / Q000032:analysis; D013058:Mass Spectrometry; D009206:Myocardium / Q000032:analysis; D010096:Oxprenolol / Q000031:analogs & derivatives / Q000652:urine; D011217:Practolol / Q000032:analysis; D011433:Propranolol / Q000031:analogs & derivatives / Q000032:analysis* / Q000097:blood; D051381:Rats; D013015:Sotalol / Q000032:analysis
D000319:Adrenergic beta-Antagonists; D004983:Ethanolamines; D005463:Fluoroacetates; D010096:Oxprenolol; D000526:Alprenolol; D011433:Propranolol; D013015:Sotalol; D007545:Isoproterenol; D011217:Practolol